Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,055 | 135 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $595.82 | 43 | $0 (2022) |
| PFIZER INC. | $344.44 | 22 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $211.80 | 12 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $198.40 | 16 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $133.91 | 5 | $0 (2019) |
| Amgen Inc. | $102.64 | 7 | $0 (2022) |
| Abbott Laboratories | $91.72 | 4 | $0 (2022) |
| Amarin Pharma Inc. | $69.31 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $49.59 | 3 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $48.48 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $263.75 | 17 | Abbott Laboratories ($71.59) |
| 2021 | $851.39 | 60 | Janssen Pharmaceuticals, Inc ($372.42) |
| 2020 | $264.19 | 20 | Janssen Pharmaceuticals, Inc ($91.54) |
| 2019 | $74.84 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($30.58) |
| 2018 | $138.67 | 5 | PFIZER INC. ($79.23) |
| 2017 | $462.45 | 28 | PFIZER INC. ($122.69) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Heart Failure | ||||||
| 05/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardio-renal | ||||||
| 03/17/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Cardiology | ||||||
| 03/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: DIABETES | ||||||
| 03/03/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/01/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Heart Failure | ||||||
| 02/23/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiology | ||||||
| 02/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Cardiovascular | ||||||
| 01/31/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Heart Failure | ||||||
| 01/19/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.10 | General |
| Category: Cardiovascular | ||||||
| 01/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/05/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $11.09 | General |
| Category: Cardiovascular | ||||||
| 11/23/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Heart Failure | ||||||
| 11/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.31 | General |
| Category: Cardiovascular | ||||||
| 10/28/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 425 | 488 | $83,719 | $22,915 |
| 2022 | 11 | 1,062 | 1,146 | $139,390 | $39,312 |
| 2021 | 19 | 2,666 | 3,125 | $235,747 | $108,562 |
| 2020 | 16 | 1,512 | 1,609 | $184,605 | $63,889 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 72 | $24,744 | $6,372 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 21 | $9,303 | $2,746 | 29.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 36 | $5,832 | $2,147 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 42 | 43 | $6,221 | $2,117 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 37 | $8,548 | $2,103 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 23 | $5,313 | $1,974 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $8,217 | $1,857 | 22.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 15 | 15 | $3,810 | $898.50 | 23.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 14 | 14 | $3,304 | $753.06 | 22.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 65 | 68 | $3,537 | $692.76 | 19.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 65 | 84 | $1,764 | $496.53 | 28.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 16 | 16 | $1,136 | $265.60 | 23.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 13 | 13 | $741.00 | $190.80 | 25.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 16 | 16 | $768.00 | $175.36 | 22.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 13 | 13 | $481.00 | $126.36 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 183 | $48,705 | $13,218 | 27.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 122 | 122 | $14,089 | $5,464 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $19,980 | $5,377 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 84 | 84 | $19,824 | $4,652 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 76 | $13,204 | $3,808 | 28.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 292 | 329 | $5,925 | $2,088 | 35.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 163 | 180 | $7,972 | $1,650 | 20.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 12 | 12 | $3,048 | $743.22 | 24.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 11 | 11 | $1,504 | $601.46 | 40.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 26 | 26 | $1,568 | $501.58 | 32.0% |
About Dr. Thomas Salvucci, DO
Dr. Thomas Salvucci, DO is a Cardiovascular Disease healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093783532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Salvucci, DO has received a total of $2,055 in payments from pharmaceutical and medical device companies, with $263.75 received in 2022. These payments were reported across 135 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,055).
As a Medicare-enrolled provider, Salvucci has provided services to 5,665 Medicare beneficiaries, totaling 6,368 services with total Medicare billing of $234,678. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Paducah, KY
- Active Since 03/10/2006
- Last Updated 12/17/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1093783532
Products in Payments
- XARELTO (Drug) $595.82
- ELIQUIS (Drug) $532.01
- LifeVest (Device) $198.40
- ENTRESTO (Drug) $133.91
- Repatha (Biological) $102.64
- CARDIOMEMS (Device) $71.59
- Vascepa (Drug) $69.31
- BRILINTA (Drug) $49.59
- OPSUMIT (Drug) $48.48
- VERQUVO (Drug) $44.24
- MULTAQ (Drug) $42.77
- JARDIANCE (Drug) $38.37
- Cardiac Monitoring Suite (Device) $26.71
- CHANTIX (Drug) $24.23
- WATCHMAN (Device) $20.69
- CardioMEMS HF System (Device) $20.13
- Kerendia (Drug) $15.39
- Livalo (Drug) $11.09
- ECM Patch,Pouch $9.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Paducah
Dr. Bradley Mcelroy, M.d, M.D
Cardiovascular Disease — Payments: $97,107
Vedran Oruc, Md, MD
Cardiovascular Disease — Payments: $54,452
Timothy Mcdermott, Md, MD
Cardiovascular Disease — Payments: $20,183
Dr. Anil Mani, M.d, M.D
Cardiovascular Disease — Payments: $7,201
Dr. Simone Fearon, M.d, M.D
Cardiovascular Disease — Payments: $5,766
Charles Hogancamp, Md, MD
Cardiovascular Disease — Payments: $2,005